U.S. Markets closed

ASLAN Pharmaceuticals Limited (ASLN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.7200-0.1600 (-8.51%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.72
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 38.1800
52 Week Low 30.8300
50-Day Moving Average 31.7409
200-Day Moving Average 31.7506

Share Statistics

Avg Vol (3 month) 3260.37k
Avg Vol (10 day) 3172.78k
Shares Outstanding 537.99M
Float 37.99M
% Held by Insiders 10.00%
% Held by Institutions 110.64%
Shares Short (Nov 12, 2020) 4204.82k
Short Ratio (Nov 12, 2020) 40.39
Short % of Float (Nov 12, 2020) 4N/A
Short % of Shares Outstanding (Nov 12, 2020) 40.54%
Shares Short (prior month Oct 14, 2020) 4207.01k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in TWD.

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-9,481.98%

Management Effectiveness

Return on Assets (ttm)-49.35%
Return on Equity (ttm)-6,043.74%

Income Statement

Revenue (ttm)189.71k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)79.82M
EBITDA -17.94M
Net Income Avi to Common (ttm)-43.12M
Diluted EPS (ttm)-1.1670
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.06M
Total Cash Per Share (mrq)0.32
Total Debt (mrq)18.66M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.09
Book Value Per Share (mrq)-0.32

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A